Product Description
Product Name: Dasatinib Tablets
Strength: 70 mg
Form: Oral Tablet
Category: Anticancer / Tyrosine Kinase Inhibitor
Indication: Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Dasatinib 70 mg Tablets are a targeted anticancer medication used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Dasatinib belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the activity of abnormal proteins that signal cancer cells to grow, thereby helping to stop or slow their spread.
